Skip to main content
Megan Haymart, MD, Endocrinology, Ann Arbor, MI

MeganRistHaymartMD

Endocrinology • Ann Arbor, MI

Diabetes, Lipid Metabolism

Assistant Professor, Internal Medicine, University of Michigan Medical School

Join to view full profile

Dr. Haymart is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Haymart's full profile

Already have an account?

  • Office

    24 Frank Lloyd Wright Dr
    Ann Arbor, MI 48105
    Phone+1 734-647-5871

Education & Training

  • University of Wisconsin Hospitals and Clinics
    University of Wisconsin Hospitals and ClinicsFellowship, Endocrinology, Diabetes, and Metabolism, 2005 - 2007
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 2002 - 2005
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 2002

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 2009 - 2025
  • WI State Medical License
    WI State Medical License 2007 - 2009
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Publications & Presentations

PubMed

Journal Articles

  • Association of the Word Cancer with Thyroid Cancer Treatment Decisions—A Rose by Any Other Name  
    Megan Haymart, MD, JAMA
  • Limitations of the 2015 ATA Guidelines for Prediction of Thyroid Cancer: A Review of 1,947 Consecutive Aspirations  
    Ashish P Wasnik, Megan R Haymart, Elaine M Caoili, Amit Pandya, The Journal of Clinical Endocrinology and Metabolism

Press Mentions

  • Haymart Gets $3.3M to Develop Risk-Based Approach to Thyroid Cancer Survivorship Care
    Haymart Gets $3.3M to Develop Risk-Based Approach to Thyroid Cancer Survivorship CareMay 6th, 2024
  • Thyroid Hormone Treatment Intensity Linked to Increased Risk of Cardiovascular Mortality
    Thyroid Hormone Treatment Intensity Linked to Increased Risk of Cardiovascular MortalityJune 17th, 2022
  • Year in Review: Five Studies Changing Thyroidology Practice
    Year in Review: Five Studies Changing Thyroidology PracticeOctober 21st, 2021
  • Join now to see all

Grant Support

  • Understanding Variation In Radioactive Iodine Use In Treatment Of Thyroid CancerNational Cancer Institute2011

Professional Memberships

Dr. Megan Haymart, Dr. Megan Haymart, MD, Dr. M Haymart, Dr. Megan Rist Haymart